Johnson & Johnson PERSIGMA Trial Advances AFib Care
Irvine, California | April 24, 2026 Johnson & Johnson has announced the launch of the PERSIGMA randomized controlled trial...
AI drug discovery artificial intelligence Autoimmune Disease biologics biopharma Biopharmaceuticals Biotechnology Bispecific Antibody Cancer Immunotherapy Cancer Research cancer therapy Cancer Treatment Cell Therapy Clinical Development Clinical Research clinical trial clinical trials Digital Health drug development Drug Discovery EMA FDA fda approval FDA clearance Gene Therapy healthcare technology Immuno-Oncology immunology Immunotherapy Medical Devices MedTech Monoclonal Antibody Neurology Oncology Ophthalmology Orphan Drug Phase 1 trial Phase 2 Trial Phase 3 Phase 3 trial Precision Medicine Precision Oncology rare disease solid tumors targeted therapy
Irvine, California | April 24, 2026 Johnson & Johnson has announced the launch of the PERSIGMA randomized controlled trial...
IRVINE, California, United States, April 7, 2026 Johnson & Johnson MedTech announced the European launch of VARIPULSEâ„¢ Pro, an...
